Bayer cut its net profit in the first quarter by 6%

German chemical and pharmaceutical concern Bayer in the first quarter reduced its net profit by 6.2% in annual terms to 1 billion 950 million euros. Analysts had expected profits at the level of 1 billion 530 million euros. The decrease is due to the negative impact of changes in exchange rates. Quarterly revenues amounted to 9 billion 140 million euros, 31% down. The forecast of the analysts had assumed revenue at the level of 9 billion 300 million euros. The Pharmaceuticals division increased quarterly sales by 2.9% to €4 billion 75 million. At the same time, the unit's EBITDA decreased by 5.8% to 1 billion 415 million euros. Revenue in the department of the non-prescription medicinal products decreased by 2.2%. In the department of veterinary drugs, the indicator grew by 3%. In the agricultural business, revenue did not change much.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong
Message: